The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

The ChemoFx® drug response assay is a treatment selection marker for chemotherapies that quantifies an individual cancer patients’ in vitro tumor response to various chemotherapeutic agents. “The drug ...

titled "DNA-methylation age and accelerated epigenetic aging in blood as a tumor marker for predicting breast cancer susceptibility." Researchers Su Yon Jung, Herbert Yu, Youping Deng, and Matteo ...

FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...

Cancer accounted for nearly 10 million deaths in 2020—almost one in every six deaths globally—according to the World Health Organization. Because the detection of abnormal diseased cellular growth ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

"The discomfort that you experience is far outweighed by the benefits," says Kristen Lindsay, who was diagnosed with breast ...

The colors correspond to gene markers identified for different ... Removal of the tumor hadn’t captured all FLC cells. Such ...

The company is in the midst of a rebranding initiative, which will soon reflect its name change to IMAC Holdings, Inc., doing business as Ignite Sciences, Inc. This transition signals its sharpened ...

Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...